Biofrontera AG B8F-FF:Frankfurt Stock Exchange

RT Quote | Exchange | EUR
Last | 8:06 AM CET
2.75quote price arrow up+0.05 (+1.85%)
52 week range
2.35 - 5.50

...

Loading . . .

KEY STATS

  • Open2.75
  • Day High2.75
  • Day Low2.75
  • Prev Close2.70
  • 52 Week High5.50
  • 52 Week High Date08/14/20
  • 52 Week Low2.35
  • 52 Week Low Date03/23/20
  • Market Cap165.53M
  • Shares Out44.85M
  • 10 Day Average Volume13,394.55
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-41.55

RATIOS/PROFITABILITY

  • EPS (TTM)-0.36
  • P/E (TTM)-7.64
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Biofrontera AG News

There is no recent news for this security.

Latest B8F-FF News From Our Partners

QUOTE FINDER

Profile

MORE
Biofrontera AG is a Germany-based biopharmaceutical company. The Company develops drugs and medicinal cosmetics for the treatment of skin diseases and regenerative care of damaged skin. Its portfolio includes: Ameluz, for photodynamic therapy (PDT) of actinic keratoses, and under development for other types of skin cancer and warts; PDT lamp BF-RhodoLED, used after the Ameluz treatment to eliminate infected cells; and Belixos, a dermatological cream with herbal ingredients...
Thomas Schaffer
Chief Financial Officer
Address
Hemmelrather Weg 201
Leverkusen
51377
Germany